Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas

Journal of the National Cancer Institute

Volumn 91, Issue 4, 1999, Pages 359-367

  Mäkitie, Teemu ^a   Summanen, Paula ^a   Tarkkanen, Ahti ^a   Kivelä, Tero ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHOROID MELANOMA; CILIARY BODY TUMOR; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR VASCULARIZATION; UVEA MELANOMA;

EID: 0033577031     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.4.359     Document Type: Article

References (37)

1. Zimmerman LE. Metastatic disease from uveal melanomas. A review of current concepts with comments concerning future research and prevention. Trans Ophthalmol Soc U K 1980; 100(Pt 1):34-54.
2. McLean IW. The biology of haematogenous metastasis in human uveal malignant melanoma. Virchows Arch A Pathol Anat Histopathol 1993;422: 433-7.
3. Shields JA, Shields CL, Donoso LA. Management of posterior uveal melanoma. Surv Ophthalmol 1991;36:161-95.
4. Albert DM, Niffenegger AS, Willson JK. Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol 1992;36: 429-38.
5. Folberg R, Pe'er J, Gruman LM, Woolson RF, Jeng G, Montague PR, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma. A matched case-control study. Hum Pathol 1992;23:1298-305.
6. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993;100: 1389-98.
7. Mooy CM, De Jong PT. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol 1996;41:215-28.
8. Mehaffey MG, Folberg R, Meyer M, Bentler SE, Hwang T, Woolson R, et al. Relative importance of quantifying area and vascular patterns in uveal melanomas. Am J Ophthalmol 1997;123:798-809.
9. Rummelt V, Folberg R, Woolson RF, Hwang T, Pe'er J. Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas. Ophthalmology 1995;102:844-51.
10. Pe'er J, Rummelt V, Mawn L, Hwang T, Woolson RF, Folberg R. Mean of the ten largest nucleoli, microcirculation architecture, and prognosis of ciliochoroidal melanomas. Ophthalmology 1994;101: 1227-35.
11. Daniels KJ, Boldt HC, Martin JA, Gardner LM, Meyer M, Folberg R. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression. Lab Invest 1996;75:55-66.
12. Folberg R, Mehaffey M, Gardner LM, Meyer M, Rummelt V, Pe'er J. The microcirculation of choroidal and ciliary body melanomas. Eye 1997;11(Pt 2):227-38.
13. Foss AJ, Alexander RA, Hungerford JL, Harris AL, Cree IA, Lightman S. Reassessment of the PAS patterns in uveal melanoma. Br J Ophthalmol 1997;81:240-6.
14. Madri JA, Basson MD. Extracellular matrix-cell interactions: dynamic modulators of cell, tissue and organism structure and function [editorial]. Lab Invest 1992;66:519-21.
15. Iozzo RV. Tumor stroma as a regulator of neoplastic behavior. Agonostic and antagonistic elements embedded in same connective tissue [editorial]. Lab Invest 1995;73:157-60.
16. Cicaloni B, Paterra N. The properties of intratumoral blood flow as a possible prognostic index in uveal melanoma: a study using color Doppler imaging. Ann Ophthalmol 1997;29:225-30.
17. McLean IW, Keefe KS, Burnier MN. Uveal melanoma. Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology 1997;104:777-80.
18. Sakamoto T, Sakamoto M, Yoshikawa H, Hata Y, Ishibashi T, Ohnishi Y, et al. Histologic findings and prognosis of uveal malignant melanoma in Japanese patients. Am J Ophthalmol 1996;121:276-83.
19. Seregard S, Spangberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology 1998;105:485-91.
20. Rummelt V, Folberg R, Rummelt C, Gruman LM, Hwang T, Woolson RF, et al. Microcirculation architecture of melanocytic nevi and malignant melanomas of ciliary body and choroid. A comparative histopathologic and ultrastructural study. Ophthalmology 1994;101:718-27.
21. Coleman DJ, Rondeau MJ, Silverman RH, Folberg R, Rummelt V, Woods SM, et al. Correlation of microcirculation architecture with ultrasound backscatter parameters of uveal melanoma. Eur J Ophthalmol 1995;5: 96-106.
22. Mueller AJ, Bartsch DU, Folberg R, Mehaffey MG, Boldt HC, Meyer M, et al. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 1998; 116:31-9.
23. Borenstein M. Planning for precision in survival studies. J Clin Epidemiol 1994;47:1277-85.
24. Parmar MK, Machin D. Survival analysis: a practical approach. Chichester (U.K.): John Wiley & Sons; 1996.
25. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Calender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983;96:502-9.
26. Fuchs U, Kivela T, Summanen P, Immonen I, Tarkkanen A. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma. Am J Pathol 1992;141:169-81.
27. Ramani P, Bradley NJ, Fletcher CD. QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections. Histopathology 1990;17:237-42.
28. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986;103(6 Pt 2):2787-96.
29. Kivela T. Immunohistochemical staining followed by bleaching of melanin: a practical method for ophthalmic pathology [letter]. Br J Biomed Sci 1995;52:325-6.
30. Burnier MN Jr, McLean IW, Gamel JW. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase. Cancer 1991;68:809-14.
31. Steuhl KP, Rohrbach JM, Knorr M, Thiel HJ. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors. Ophthalmology 1993;100:208-15.
32. Luyten GP, Mooy CM, Post J, Jensen OA, Luider TM, de Jong PT. Melastatic uveal melanoma. A morphologic and immunohistochemical analysis. Cancer 1996;78:1967-71.
33. Bodey B, Kaiser HE, Goldfarb RH. Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy. Anticancer Res 1996;16:517-31.
34. Altman DG. Practical statistics for medical research. London (U.K.): Chapman & Hall; 1991.
35. Kleinbaum DG. Survival analysis: a self-learning text. New York (NY): Springer-Verlag; 1996.
36. Gamel JW, McCurdy JB, McLean IW. A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci 1992;33: 1919-22.
37. Folberg R. Reassessment of the PAS patterns in uveal melanoma [discussion]. Br J Ophthalmol 1997;81:247-8.